Search - tctmd.com

Displaying 261 - 280 of 1511

Sort: Relevancy | Date

Podcast TCTMD Talking Points

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

May 15, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

News Daily News

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Michael O'Riordan

May 02, 2019

News Industry News

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

May 02, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

News Industry News

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

April 10, 2019

Presentation SIF 2019

PCI vs. CABG for Multivessel CAD

Presenter: Sripal Bangalore

March 28, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

Presentation SIF 2019

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Presenter: Douglas E. Drachman

March 27, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

Presentation JIM 2019

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Presenter: Luca Testa

February 14, 2019

Presentation JIM 2019

Unmet Clinical Needs With Current Drug-Eluting Stents

Presenter: Davide Capodanno

February 14, 2019

News Conference News ISET 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Caitlin E. Cox

January 30, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Todd Neale

November 12, 2018

Advertisement

TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Update: Drug-Eluting Stents

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

PCI vs. CABG for Multivessel CAD

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Unmet Clinical Needs With Current Drug-Eluting Stents

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Top News in Coronary Artery Disease: 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content